baber/WOPTO huggingface dataset:
Patent PT-2319560-E (PT)
Title: Injection device
Inventor: HARRISON NIGEL
IPC: A61M5/32
Filed: 2005-05-27
Abstract: An injection device (110) is described having a housing (112) that receives a syringe (114) having a needle (118), wherein the syringe is supported in a syringe carrier (150). The syringe and syringe carrier are biased by a return spring (126) from an extended position in which the needle (118) extends from the housing (112) through an exit aperture (128) to a retracted position in which it does not. A drive spring (130) acts via a drive to advance the syringe from its retracted position to its extended position and discharge its contents through the needle and a return spring, brought into play when the drive has reached a nominal return position, restores the syringe to its retracted position.
Patent PT-1985963-E (PT)
Title: A fog generator
Inventor: VANDONINCK ALFONS
IPC: F41H9/06
Filed: 2007-04-27
Abstract: The present invention is directed to a fog generator comprising a vessel that contains a fog generating fluid and a propellant gas for driving the fog generating fluid from the vessel into a heat exchanger which transforms the fog generating fluid into steam and is connected with the vessel, and a valve positioned between the vessel and the heat exchanger, characterized in that the propellant gas is a compressed gas and that the valve is adapted for controlling the fog generating fluid flow rate.
Patent PT-1810679-E (PT)
Title: Controlled release oxycodone compositions
Inventor: KAIKO ROBERT FRANCIS
IPC: A61K47/44
Filed: 1992-11-25
Abstract: (A) Controlled release oxycodone formulation for oral admin. to human patients, comprises (i) 10-40mg oxycodone or its salt, the formulation providing a mean max. plasma conc. of oxycodone of 6-60 ng/ml from a mean of 2-4.5 hrs.. After admin., and a mean min. plasma conc. of 3-30 ng/ml from a mean of 10-14 hrs. after repeated admin. every 12 hrs. through steady state conditions. (ii) 10-160 mg oxycodone or its salt, the formulation providing a mean max. plasma conc. of oxycodone of 6-240 ng/ml from a mean of 2-4.5 hrs. after admin., and a mean min. plasma conc. from 3-120 ng/ml from a mean of 10-14 hrs. after repeated admin. every 12 hrs. through steady-state conditions. (B) Also claimed is a solid controlled release oral dosage form comprising (i) oxycodone or its salt in amt. of 10-160 mg; a controlled release matrix selected from hydrophilic hydrophobic polymers, digestible opt. substd. 8-50C hydrocarbons, and/or polyalkylene glycols; and a diluent; wherein the compsn. provides a mean max. plasma conc. of oxycodone of 6-240 ng/ml from a mean of 2-4.5 hrs. after admin, and mean min. plasma conc. of 3-120 ng/ml from a mean of 10-14 hrs. after repeated admin. every 12 hrs. through steady-state conditions; or (ii) an analgesically effective amt. of spheroids comprising oxycodone or its salt and either a spheronising agent or an acrylic polymer or copolymer, such that the total dosage of oxycodone in the dosage form is 10-160 mg; a film coating which controls the release of the oxycodone or its salt at a controlled rate in an aq. medium, wherein the compsn. provides an in vitro dissolution rate of the dosage form.
Patent PT-1991564-E (PT)
Title: Virosome-like vesicles comprising gp41-derived antigens
Inventor: ZURBRIGGEN RINALDO
IPC: A61K9/127
Filed: 2007-03-02
Abstract: The present invention relates to a virosome-like vesicle comprising at least a gp41-derived antigen or an analogue thereof, said gp41-derived antigen being located to the external surface of and/or encapsulated inside said vesicle and being in a convenient configuration for conferring said virosome-like vesicle with an ability to induce an immune response against a gp41 protein or a human immunodeficiency virus (HIV).
Patent PT-2427713-E (PT)
Title: Heat storage comprising at least one storage element
Inventor: DOERBECK TILL
IPC: F27D1/04
Filed: 2010-04-27
Abstract: The invention relates to a heat store (1) having at least one storage element (3) comprising molded stones (4) made of ceramic layered on top of each other, substantially disposed in a wall composite (13), wherein each molded stone (4) comprises a substantially rectangular and/or triangular cross section, at least some of the molded stones (4) particularly comprise feet (17) reducing heat transfer from one molded stone (4) to another molded stone (4), said feet being provided in the corners of the molded stone (4) and formed by machining away the molded stone (4) at the lower end thereof, wherein a transverse flow chamber (14) having a circular cross-section and having lateral overflow openings (27) is simultaneously formed by machining, and the overflow openings (27) interact with overflow openings (27) of further molded stones (4) for increasing the transverse flow chamber (14) across a plurality of adjacently disposed molded stones (4).
Patent PT-640098-E (PT)
Inventor: JONES ELAINE VERNE
IPC: C07K19/00
Filed: 1993-05-07
Abstract: The present invention provides the amino acid and nucleotide sequences of a CCV spike gene, and compositions containing one or more fragments of the spike gene for prophylaxis, diagnostic, and treatment of CCV infections.
Patent PT-681843-E (PT)
Inventor: SUTTON ANDREW DEREK
IPC: A61K9/16
Filed: 1992-04-10
Abstract: Microcapsules are prepared by a process comprising the steps of (i) spray-drying a solution or dispersion of a wall-forming material in order to obtain intermediate microcapsules and (ii) reducing the water-solubility of at least the outside of the intermediate microcapsules.Suitable wall-forming materials include proteins such as albumin and gelatin.The microcapsules have walls of 40-500 nm thick and are useful in ultrasonic imaging. The control of median size, size distribution and degree of insolubilisation and crosslinking of the wall-forming material allows novel microsphere preparations to be produced.
Patent PT-792165-E (PT)
Inventor: NEW ROGER RANDAL CHARLES
IPC: A61K47/44
Filed: 1995-11-14
Abstract: An immunogenic composition comprising an immunogen solubilised, or otherwise distributed, in a hydrophobic solvent in the absence of a hydrophilic phase. Preferably, the immunogenic composition is provided as an oral vaccine.
Patent PT-800407-E (PT)
Inventor: AKTIEBOLAG BENRAD
IPC: B01D53/70
Filed: 1995-12-22
Abstract: The invention relates to a method for treatment of fluids, the invention being characterized in that ozone is generated in the medium, which ozone is exposed to UV radiation at the same time as it is being generated, so that the ozone is broken down and free radicals are obtained. The invention also relates to an apparatus in accordance with the method, which apparatus comprises an enclosure (1) provided with at least one inlet (2) and at least one outlet (3). The apparatus is characterized in that an oxidizing member (4) is arranged in the enclosure (1) and generates ozone and at the same time breaks down the ozone to free radicals.
Patent PT-721947-E (PT)
Inventor: LESIEUR DANIEL
IPC: C07C275/24
Filed: 1996-01-10
Abstract: Hetero-cycloalkyl derivs. of formula (I) and their enantiomers and diastereoisomers are new. R1 = alkyl opt. substd. by Q; or cycloalkyl or cycloalkylalkyl, both opt. substd. by Q'; A together with the benzene gp. = tetrahydronaphthalene, dihydronaphthalene, naphthalene, benzothiophene, 2,3-dihydrobenzothiophene; or indoline or indole both opt. N-substd. by Ra, CORa or CO2Ra; Ra = alkyl, Ph or phenylalkyl; R2 = H or alkyl; R3 = C(=X)R4 or C(=X')NHR5; X, X' = S or O; R4 = H, alkenyl, alkynyl, alkyl opt. substd. by Q, or cycloalkyl or cycloalkylalkyl both opt. substd. by Q'; R5 = H, alkyl opt. substd. by Q, or cycloalkyl or cycloalkylalkyl both opt. substd. by Q'; alkyl, alkoxy = 1-6C; alkenyl, alkynyl = 2-6C; cycloalkyl = 3-8C; Q = halo, OH, alkyl or alkoxy; Q' = halo, alkyl or oxo.
Patent PT-814701-E (PT)
Inventor: MCGAFFIGAN THOMAS H
IPC: A61B5/028
Filed: 1996-02-15
Abstract: A heater (12) for a catheter (10) used in monitoring constant cardiac output is fabricated using a bifilar wire (21) coated with polyvinyl chloride (PVC) like the material used for the catheter. The bifilar wire is coated with the PVC using a conventional extrusion technique, producing a coated lead (24, 32). This coated lead is wrapped around the exterior surface of the catheter, forming a helical coil. Heat is applied to the coated lead to melt the PVC coating, causing it to bond the lead to the catheter. The melted PVC also flows into gaps (23) or notches between adjacent coils of the lead, producing a relatively smooth outer surface for the heater coil when the PVC coating cools. The bifilar wire can alternatively be wrapped in-line with PVC tape (29) or film and the PVC material heated to flow around the wire, bonding it to the catheter's outer surface.
Patent PT-799950-E (PT)
Inventor: FOUR GILLES
IPC: E04G11/06
Filed: 1997-04-03
Abstract: The shuttering panel, especially for concrete structures, consists of a metal sheet (2) equipped with a series of regularly-spaced lengthwise supporting beams and transverse templates (1), e.g. at the top and bottom, to vary the curvature of the metal sheet. The templates are pressed against the surface of the metal sheet by fastenings (8) and adjusted by means of regulating elements (4, 5, 6, 7). The templates can be made from wood, plastic or nylon, and each one has a central groove for a seal.
Patent PT-916656-E (PT)
Inventor: NAGASE HIROSHI
IPC: C07D207/26
Filed: 1998-11-13
Abstract: A compound represented by the following formula (12) useful as an intermediate for production of drug or agricultural chemical: <CHEM> (wherein R<21> to R<25> are each independently a hydrogen atom, a hydroxyl group, a halogen atom, an alkyl group of 1 to 4 carbon atoms, an alkoxy group of 1 to 4 carbon atoms, a perfluoroalkyl group of 1 to 4 carbon atoms, a cyano group, a nitro group, an amino group, a carboxyl group, a thiol group, an alkylthio group of 1 to 4 carbon atoms or a carbamoyl group) can be produced by reacting a compound represented by the formula (13): <CHEM> (wherein R<21> to R<25> have the same definitions as given above) with 1,1-cyclopropanedicarboxylic acid. The compound of the formula (12) is useful as a raw material for production of a pyrrolidinone compound useful as an active ingredient of drug.
Patent PT-966735-E (PT)
Inventor: MOSHER WALTER W JR
IPC: G06K19/07
Filed: 1998-03-03
Abstract: A radio frequency identification device includes an attachment element (12) which is maintained in operative relationship with an object or individual by a securement element (14). The attachment element (14) is disposable and the securement element (14) is easily separable therefrom for reuse, the securement element (14) including a radio frequency identification circuit (30) which can be reused after the attachment element (12) has been disposed of. One form of the radio frequency identification device is an identification wristband (10) which incorporates attachment element (12) and securement element (14) for the attachment element (12), the securement element (14) incorporating an RFID such as a chip (30) which is removed from operative relationship with the attachment element (12) when the securement element (14) is removed to permit reuse of the securement element (14) and chip (30).
Patent PT-984948-E (PT)
Inventor: ASSMANN LUTZ
IPC: C07D271/07
Filed: 1998-04-06
Abstract: PCT No. PCT/EP98/01990 Sec. 371 Date Oct. 13, 1999 Sec. 102(e) Date Oct. 13, 1999 PCT Filed Apr. 6, 1998 PCT Pub. No. WO98/47883 PCT Pub. Date Oct. 29, 1998Novel sulphonyloxadiazolones of the formula in which A represents oxygen, sulphur, -SO-, -SO2- or where R3 represents hydrogen or alkyl, R1 represents optionally substituted cycloalkyl, optionally substituted cycloalkenyl or optionally substituted aryl and R2 represents in each case optionally substituted alkyl, alkenyl, dialkylamino or aryl a process for preparing these substances and their use as microbicides in crop protection and in the protection of materials.
Patent PT-1015002-E (PT)
Inventor: BRYSON ROBERTS NORMAN
IPC: C01B32/60
Filed: 1998-09-18
Abstract: A mixed metal compound for pharmaceutical use is free from aluminium and has a phosphate binding capacity of at least 30 %, by weight of the total weight of phosphate present, over a pH range of from 2-8. The compound is especially useful for treatment of hyperphosphataemia. The metals are preferably iron (III) and at least one of calcium, magnesium, lanthanum and cerium. A metal sulphate for pharmaceutical use is selected from at least one of calcium, lanthanum and cerium sulphate compounds and has a phosphate binding capacity of at least 30 % by weight of the total phosphate present, over a pH range from 2-8.
Patent PT-1109795-E (PT)
Inventor: BERGERON RAYMOND J JR
IPC: C07D277/56
Filed: 1999-08-31
Abstract: Phenyl- and pyridyl-substituted thiazoline acid derivatives useful in diagnosing and treating pathological conditions associated with an excess of trivalent metals in humans and animals.
Patent SG-16084-G (SG)
Title: Improvements to supercharged internal combustion engines,inter alia diesel engines
IPC: F23R3/26
Filed: 1984-02-23
Abstract: In a supercharged engine, a bypass connected to the compressor delivery pipe (4) supplies the turbine with all the air which has not been absorbed by the engine. The bypass (4) is divided into a first branch which supplies combustive air to the primary region (10) of an auxiliary combustion chamber and a second branch which supplies diluting air to the secondary region of the aforementioned chamber and comprises first throttle means. The first branch has second throttle means (13) comprising coupled orifices (14, 15) formed respectively on an inner sleeve (16) and an outer sleeve (17) movable relative to one another. According to the invention, a radial clearance (a) is maintained between the sleeves (16, 17) irrespective of their respective temperatures. Third throttle means (45), having a zero minimum flow section, are provided upstream or level with the second means (13).
Patent SG-58992-G (SG)
Title: Integrated circuit device having strip line structure therein
IPC: H01P5/08
Filed: 1992-06-03
Abstract: @ An integrated circuit device (1) includes at least one semiconductor chip (3) having a plurality of circuit elements; a package (21 to 24) enclosing the semiconductor chip with a hermetic seal; and a strip line unit (15-2, 11-lb, 11-2, 20 and 23 : 15-1, 11-1, 11-2, 11-3, 12-1 and 20) for connecting the circuit elements in the semiconductor chip to circuitry outside the package. The stripline unit has a microstrip line structure and a triplate strip line structure serial-connected to the microstrip line structure and connecting the outside circuits. The triplate strip line structure has a characteristic impedance equal to that of the microstrip line structure so that the strip line unit satisfies the required impedance matching.A center of the conductive layer strip line of the triplate strip line structure has a smaller width than that of a microstrip line of the microstrip line structure to have a predetermined impedance so that the triplate strip line structure has a same characteristic impedance as that of the microstrip line structure.
Patent IE-820140-L (IE)
Title: Electrostatic sprayer
IPC: B05B5/025
Filed: 1982-01-22
Abstract: A hand-held electrostatic sprayer for use in a process for the electrostatic spraying of pesticides by producing a descending cloud of charged pesticide particles and impressing a lateral component of motion upon the cloud with the aid of a laterally disposed electrode charged in the same sense as the cloud, the sprayer including an elongated body forming the sprayer handle and having: a neck supporting a downwardly-directed electrostatic sprayhead; a reservoir for supplying liquid to the sprayhead; and a high voltage generator for charging the sprayhead to a high potential, wherein the neck carries one or more conductive elements extending downwardly from the neck beyond the sprayhead for impressing a lateral component of motion upon a cloud of charged liquid particles from the sprayhead, the elements being electrically connected to high potential of the same sign as the sprayhead.
[US4470550A]
Patent IE-42476-L (IE)
Title: Dinitronaphthalenes
IPC: C07C205/06
Filed: 1976-02-11
Abstract: 1480469 Preparation of dinitronaphthalenes BAYER AG 11 Feb 1976 [12 Feb 1975] 05393/76 Heading C2C A process for the preparation of a dinitronaphthalene comprises reacting a nitronaphthalene at a temperature of from 20 to 50 C. with 60 to 80% strength by weight aqueous nitric acid and separating the dinitronaphthalene from the reaction mixture. The residual nitric acid may then be enriched with more highly concentrated nitric acid until a concentration of 60 to 80% by weight is reached and then used in a further nitrating reaction. In general 4 to 12 mols of nitric acid are reacted with 1 mol of nitronaphthalene.
[GB1480469A]
Patent IE-800763-L (IE)
Title: Indentification of objects such as nuclear fuel elements
IPC: G09F3/03
Filed: 1980-04-15
Abstract: A system, suitable for use as an identity seal for an object, such as a container for fissile material, comprises a body including a cap for fitting over one end of the object, and a recess which contains a material such as "ARALDITE" or aluminium acting as a matrix for a plurality of inclusions of e.g. bronze embedded therein in a random configuration. The recess is closed by a cover which includes a central electrically conductive part. Also embedded in the matrix material and constituting further "inclusions" are two piezoelectric crystal transducers each electrically connected to the central cover part. In use, the transducers are electrically connected via the central cover part to external ultrasonic testing apparatus to provide a unique output indicative of the particular structure of the seal particularly the inclusion configuration and hence providing a unique "identity" and hence indication of integrity for the seal. Tampering with and/or removal of the seal will change its structure in some way so that subsequent ultrasonic testing produces a different output, revealing the occurrence of the unauthorized event.
[US4359903A]
Patent IE-900818-L (IE)
Title: Therapeutic agents
IPC: A61P9/00
Filed: 1990-03-07
Abstract: A product containing a therapeutically effective amount of an angiotensin-converting enzyme (ACE) inhibitor and a therapeutically effective amount of a compound of formula (I), wherein n is 1 or 2. The preferred compound of formula (I) is 7-fluoro-1-methyl-3-methyl-sulphinyl-4-quinolone. The compound of formula (I) and the ACE inhibitor may be administered concomitantly or concurrently and combined preparations for simultaneous, separate or sequential use are described. Concomitant administration may be by novel pharmaceutical compositions comprising a compound of formula (I), an ACE inhibitor and a pharmaceutically acceptable carrier.
Patent FI-822693-L (FI)
Inventor: SCHOBERTH HANS
IPC: A21D2/18
Filed: 1982-08-02
Abstract: Disclosed is a bread flour comprising bread cereal flour, cereal bran and self-rising starch flour and method for making a leavened bread by preparing a dough having bread cereal flour, water, leavening agents, soy bran and self-rising starch flour which is subjected to baking, the said soy bran being in an amount equal to 10 to 30% by weight of the bread cereal flour and the said self-rising starch flour being in an amount equal to 2 to 8% by weight of bread cereal flour.
Patent FI-852068-L (FI)
Inventor: BARTSCH ADALBERT
IPC: C25C7/02
Filed: 1985-05-23
Abstract: A current-feeding cathode-mounting device comprises a metal-sheathed carrying rail of copper and a permanent cathode plate consisting of the same material as the sheath and joined by welding at least along part of a longitudinal edge and wherein at least an end portion of the rail is unsheathed at least along part of its extent. In order to increase the creep strength and durability and to ensure a low-resistance contact, the carrying rail consists of a hollow copper section, the sheath consists of special steel, the sheath is joined to the carrying rail by a diffusion-preventing non-porous weld, and the permanent cathode of special steel is joined to the sheath by an interrupted seal weld. The carrying rail consists suitably of a copper tube. In accordance with a further feature the copper tube provided with a special steel sheath has been deformed to constitute a composite having an elliptical or oval cross-section or a cross-section having two parallel sides, and the major axis of said cross-section lies in the plane of the cathode plate.
Patent IE-33577-L (IE)
Title: Tyres, reinforcing layer
IPC: B60C9/20
Filed: 1969-09-01
Abstract: 1282874 Pneumatic tyres DUNLOP HOLDINGS Ltd 4 Sept 1969 [5 Sept 1968] 42261/68 Heading B7C A pneumatic tyre comprises at least one reinforcement layer, e.g. a filler strip or a chafer strip, the said layer being located solely in a region radially inwardly of a tread shoulder of the tyre and being of rubberized cord fabric comprising steel wires each wire having a diameter of 0À003 inch or less. Preferably the cords consist of wires having a diameter of 0À0016 inch or less twisted into two yarns, which yarns are twisted together with 7¢ turns per inch forming cords of a diameter of substantially 0À038 inch. In a radial tyre the cords of the layer may extend at an angle of at least 40 degrees, preferably 70 degrees to the cords of the carcase ply.
[GB1282874A]
Patent IE-35751-L (IE)
Title: Sewing machine case
IPC: D05B77/00
Filed: 1971-10-19
Abstract: 1316400 Sewing machine cases MEFINA S A 19 Oct 1971 [6 Nov 1970] 48498/71 Heading A4B A case for a sewing machine having a base 10 surmounted by a free arm 13, comprises a boxlike pedestal 1 for housing the base 10 and arm 13 and having an upper surface 15 with an opening 14 shaped to receive the arm 13, the surface 15 defining a small work table at the level of the flat upper face 16 of the free arm 13, a plurality of flaps 2-5 hinged to the upper edge of the pedestal 1 for pivotal movement between a lowered position and a raised position in which they form walls of the case, and a cover 6 releasably secured by catches (7, 8), Fig. 1 (not shown) to close the case about the machine. As shown, the cover 6 is hinged to one flap 5. An alternative cover comprises two parts respectively hinged to the flaps 2 and 5. One wall 17 of the pedestal 1 may be hinged down to allow removal of the machine. A slidable or hinged accessory box 18 may be housed in the pedestal 1. A carrying handle is secured to the cover.
[GB1316400A]
Patent IE-37043-L (IE)
Title: Pyrimidones
IPC: A61P11/08
Filed: 1972-10-16
Abstract: 1377308 Substituted 5-phenoxy and 5-thiophenoxy-2-(1H)-pyrimidinones PFIZER Inc 18 Feb 1972 [29 Oct 1971] 7748/72 Heading C2C Novel compounds of the Formula I: wherein R is hydrogen or methyl, R 1 is oxygen or sulphur, R 2 is hydrogen, halogen or methyl and R 3 is hydrogen, methyl, chloro or trifluoromethyl and pharmaceutically acceptable salts thereof may be prepared by reacting a compound wherein R 6 and R 7 are C 1-3 alkyl groups, with a reagent prepared from ethanol, sodium and urea and if necessary reacting the product with an alkali metal or alkaline earth metal salt and hot methyl iodide to introduce the methyl group at R. 2 - (p - Chlorophenoxy) - 3 - dimethylaminoacrolein may be prepared by reacting potassium p-chlorophenolate, prepared in situ, with chloroacetaldehyde diethylacetal to yield pchlorophenoxyacetaldehyde diethyl acetal which on reaction with dimethyl formamide in the presence of phosphorus oxychloride cyclizes to the required intermediate. Pharmaceutical compositions of the compound I with the usual excipients show bronchodilatory activity and inhibit gastric acid secretion when administered orally, parenterally or by inhalation.
[GB1377308A]